前臨床イメージングの世界市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

前臨床イメージング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の前臨床イメージングの市場規模は2030年までに59億6,000万米ドルに達し、2025年から2030年にかけてCAGR 4.36％で成長すると予測されています。

研究開発への多額の投資は、世界中の研究プロジェクトを後押ししています。その結果、前臨床イメージングの需要は着実に増加しています。医薬品、バイオテクノロジー、ライフサイエンス、医療機器、化粧品は、研究開発でイメージングモダリティが広く使用されている応用分野です。さらに、動物病院や教育機関もこの市場に新たな需要を生み出しています。

核医学技術（主に陽電子放射断層撮影法（PET）と単一光子放射コンピュータ断層撮影法（SPECT））、光学イメージング、マイクロコンピュータ断層撮影法（CT）、マイクロ磁気共鳴画像法（MRI）、光音響トモグラフィ（PAT）、超音波は、小動物の生体内イメージング用途に最も適したモダリティです。各モダリティにはそれぞれ利点と欠点があります。研究対象の病態生理学的プロセスに関する補完的な情報を提供するために設計されたマルチモダリティ装置は、各イメージングモダリティ固有の限界を克服することを目指し、急速に普及しています。micro-CTやmicro-MRIのような高解像度モダリティと、micro-PETやmicro-SPECTのような機能的情報を提供する高感度技術の組み合わせは、感染症、腫瘍学、循環器学、神経学のような主要分野における研究の視野を広げ、疾患の基礎メカニズムの理解に貢献するだけでなく、新規化学物質や候補薬剤を評価するための効率的でユニークなツールを提供し、世界市場の成長を後押しすると期待されています。

世界市場の主要な競合企業は、新製品の上市や製造能力の強化など、製品ポートフォリオの充実を図るためにさまざまな取り組みを行っています。例えば、2023年2月に開催された第75回インド放射線画像学会（Indian Radiological and Imaging Association）において、FUJIFILM Indiaは機器とサービスの開発を発表しました。同社は2023年2月2日から5日までアムリトサルで開催されたイベントで、最先端の診断ツールを実演しました。最近発売されたMRI装置APERTO Lucent Non DICOMプリンターAPEOS、超音波診断装置Arietta 650 DeepInsightおよびArietta 850 DeepInsightは、すべて新しいポートフォリオの構成要素です。また、スマートフォン用アプリケーション「FUJIFILM Connect」もリリースされました。

さらに、がん研究・調査のアプリケーションで使用される高スループット超音波イメージングシステムの進歩が市場を押し上げます。2022年4月、パーキンエルマーはライブ画像解析の拡大を発表したが、その一環として、がん、腎臓・肝臓病、心臓病などの分野における非侵襲的臨床研究や創薬を加速できる、完全自動化技術とハイスループット能力を備えたハンドヘルド超音波イメージングシステム「Vega」を発売しました。非侵襲的イメージング法は、動物の不快感を最小限に抑えつつ、侵襲的手術の必要性を低減するため、その使用が奨励されています。前臨床イメージング技術は、このような倫理的配慮の結果として採用されています。

前臨床イメージング市場：分析概要

• 光学イメージングセグメントは、小動物イメージングや新薬探索プロジェクトでの幅広い使用により、2024年に13.6%の最大収益シェアを占めました。
• 用途別では、研究開発分野が2024年に最大の収益シェアを獲得しました。
• 製薬・バイオテクノロジー企業のセグメントは、2024年に39.9%の最大収益シェアを獲得しました。バイオテクノロジー企業における前臨床イメージングの需要は近年着実に増加しており、今後も成長が見込まれます。
• 北米の前臨床イメージング市場は、2024年に30.1%の最大収益シェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 前臨床イメージング市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 前臨床イメージング市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 前臨床イメージング市場：製品別の推定・動向分析

• セグメントダッシュボード
• 前臨床イメージング市場：製品別の変動分析
• 前臨床イメージング市場：市場規模の予測と動向分析、製品別 (2018～2030年)
• CT
• MRI
• PET/SPECT
• マルチモーダル
• 光学
• 超音波
• 光音響
• 試薬
• サービス

第5章 前臨床イメージング市場：用途別の推定・動向分析

• セグメントダッシュボード
• 前臨床イメージング市場：用途別の変動分析
• 前臨床イメージング市場：市場規模の予測と動向分析、用途別 (2018～2030年)
• 研究開発
• 創薬

第6章 前臨床イメージング市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• 前臨床イメージング市場：最終用途別の変動分析
• 前臨床イメージング市場：市場規模の予測と動向分析、最終用途別 (2018～2030年)
• 製薬・バイオテクノロジー企業
• 研究機関
• その他

第7章 前臨床イメージング市場：地域別の推定・動向分析（製品別、用途別、最終用途別）

• 市場シェア分析：地域別 (2023年・2030年)
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 市場規模の予測と動向分析 (2018年～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最新動向と影響分析：主な市場参入企業別
• 企業/競合の分類
• 主要企業の市場シェア分析（2025年）
• 企業ポジション分析
• 企業の分類（新興企業、イノベーター、リーダー）
• 企業プロファイル
  • Bruker Corporation
  • Siemens AG
  • General Electric（GE）
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • VisualSonics Inc.（Fujifilm）
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs BV
  • MR Solutions
  • Molecubes

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America preclinical imaging market, By country, 2018 - 2030 (USD Million)
• Table 3 North America preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 4 North America preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 5 North America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 6 U.S. preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 7 U.S. preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 8 U.S. preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 9 Canada preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 10 Canada preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 11 Canada preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 12 Mexico preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 13 Mexico preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 14 Mexico preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 15 Europe preclinical imaging market, By country, 2018 - 2030 (USD Million)
• Table 16 Europe preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 17 Europe preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 18 Europe preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 19 UK preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 20 UK preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 21 UK preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 22 Germany preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 23 Germany preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 24 Germany preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 25 France preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 26 France preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 27 France preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 28 Italy preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 29 Italy preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 30 Italy preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 31 Denmark preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 32 Denmark preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 33 Denmark preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 34 Sweden preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 35 Sweden preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 36 Sweden preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 37 Norway preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 38 Norway preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 39 Norway preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific preclinical imaging market, By country, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 44 Japan preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 45 Japan preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 46 Japan preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 47 China preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 48 China preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 49 China preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 50 India preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 51 India preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 52 India preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 53 Australia preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 54 Australia preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 55 Australia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 56 South Korea preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 57 South Korea preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 58 South Korea preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 59 Thailand preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 60 Thailand preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 61 Thailand preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 62 Latin America preclinical imaging market, By Country, 2018 - 2030 (USD Million)
• Table 63 Latin America preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 64 Latin America preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 65 Latin America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 66 Brazil preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 67 Brazil preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 68 Brazil preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 69 Argentina preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 70 Argentina preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 71 Argentina preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 72 Middle East & Africa preclinical imaging market, By country, 2018 - 2030 (USD Million)
• Table 73 Middle East & Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 74 Middle East & Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 75 Middle East & Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 76 South Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 77 South Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 78 South Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 80 Saudi Arabia preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 81 Saudi Arabia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 82 UAE preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 83 UAE preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 84 UAE preclinical imaging market, By end use, 2018 - 2030 (USD Million)
• Table 85 Kuwait preclinical imaging market, By product, 2018 - 2030 (USD Million)
• Table 86 Kuwait preclinical imaging market, By application, 2018 - 2030 (USD Million)
• Table 87 Kuwait preclinical imaging market, By end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Dermatology imaging devices market: Market outlook
• Fig. 14 Dermatology imaging devices market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Preclinical imaging market driver impact
• Fig. 20 Preclinical imaging restraint impact
• Fig. 21 Preclinical imaging market: product movement analysis
• Fig. 22 Preclinical imaging market: product outlook and key takeaways
• Fig. 23 CT market estimates and forecast, 2018 - 2030
• Fig. 24 MRI market estimates and forecast, 2018 - 2030
• Fig. 25 PET/SPECT market estimates and forecast, 2018 - 2030
• Fig. 26 Multi Modal market estimates and forecast, 2018 - 2030
• Fig. 27 Optical market estimates and forecast, 2018 - 2030
• Fig. 28 Ultrasound market estimates and forecast, 2018 - 2030
• Fig. 29 Photoacoustic market estimates and forecast, 2018 - 2030
• Fig. 30 Reagents market estimates and forecast, 2018 - 2030
• Fig. 31 Services market estimates and forecast, 2018 - 2030
• Fig. 32 Preclinical imaging market: application movement analysis
• Fig. 33 Preclinical imaging market: application outlook and key takeaways
• Fig. 34 Research and development market estimates and forecast, 2018 - 2030
• Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030
• Fig. 36 Preclinical imaging market: end use movement analysis
• Fig. 37 Preclinical imaging market: end use outlook and key takeaways
• Fig. 38 Pharma and biotech companies market estimates and forecast, 2018 - 2030
• Fig. 39 Research institutes market estimates and forecast, 2018 - 2030
• Fig. 40 Global Dermatology imaging devices market: regional movement analysis
• Fig. 41 Global Dermatology imaging devices market: regional outlook and key takeaways
• Fig. 42 North America
• Fig. 43 North America market estimates and forecast, 2018 - 2030
• Fig. 44 U.S.
• Fig. 45 U.S. market estimates and forecast, 2018 - 2030
• Fig. 46 Canada
• Fig. 47 Canada market estimates and forecast, 2018 - 2030
• Fig. 48 Mexico
• Fig. 49 Mexico market estimates and forecast, 2018 - 2030
• Fig. 50 Europe
• Fig. 51 Europe. market estimates and forecast, 2018 - 2030
• Fig. 52 UK
• Fig. 53 UK market estimates and forecast, 2018 - 2030
• Fig. 54 Germany
• Fig. 55 Germany market estimates and forecast, 2018 - 2030
• Fig. 56 France
• Fig. 57 France market estimates and forecast, 2018 - 2030
• Fig. 58 Italy
• Fig. 59 Italy market estimates and forecast, 2018 - 2030
• Fig. 60 Spain
• Fig. 61 Spain market estimates and forecast, 2018 - 2030
• Fig. 62 Denmark
• Fig. 63 Denmark market estimates and forecast, 2018 - 2030
• Fig. 64 Sweden
• Fig. 65 Sweden market estimates and forecast, 2018 - 2030
• Fig. 66 Norway
• Fig. 67 Norway market estimates and forecast, 2018 - 2030
• Fig. 68 Asia Pacific
• Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 70 Japan
• Fig. 71 Japan market estimates and forecast, 2018 - 2030
• Fig. 72 China
• Fig. 73 China market estimates and forecast, 2018 - 2030
• Fig. 74 India
• Fig. 75 India market estimates and forecast, 2018 - 2030
• Fig. 76 South Korea
• Fig. 77 South Korea market estimates and forecast, 2018 - 2030
• Fig. 78 Thailand
• Fig. 79 Thailand market estimates and forecast, 2018 - 2030
• Fig. 80 Australia
• Fig. 81 Australia market estimates and forecast, 2018 - 2030
• Fig. 82 Latin America
• Fig. 83 Latin America market estimates and forecast, 2018 - 2030
• Fig. 84 Brazil
• Fig. 85 Brazil market estimates and forecast, 2018 - 2030
• Fig. 86 Argentina
• Fig. 87 Argentina market estimates and forecast, 2018 - 2030
• Fig. 88 Middle East and Africa
• Fig. 89 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 90 Saudi Arabia
• Fig. 91 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 92 South Africa
• Fig. 93 South Africa market estimates and forecast, 2018 - 2030
• Fig. 94 UAE
• Fig. 95 UAE market estimates and forecast, 2018 - 2030
• Fig. 96 Kuwait
• Fig. 97 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 98 Participant categorization- Preclinical imaging market
• Fig. 99 Market share of key market players- Preclinical imaging market

Preclinical Imaging Market Growth & Trends:

The global preclinical imaging market size is estimated to reach USD 5.96 billion by 2030, registering to grow at a CAGR of 4.36% from 2025 to 2030 according to a new report by Grand View Research, Inc. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights:

• The optical imaging segment held the largest revenue share of 13.6% in 2024 owing to their wide usage in small animal imaging and new drug discovery projects.
• In terms of application, the research & development segment captured the largest revenue share in 2024.
• The pharma and biotech companies segment captured the largest revenue share of 39.9% in 2024. The demand for pre-clinical imaging in biotech companies has been steadily increasing in recent years and is expected to continue growing in the coming years.
• North America preclinical imaging market held the largest revenue share of 30.1% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Technological advancements
    • 3.2.1.2. Growing number of investments and funding in research and development
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Strict regulatory framework
• 3.3. Preclinical Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Preclinical Imaging Product Market Movement Analysis
• 4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. CT
  • 4.4.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. MRI
  • 4.5.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. PET/SPECT
  • 4.6.1. PET/SPECT market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Multi Modal
  • 4.7.1. Multi modal market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Optical
  • 4.8.1. Optical market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Ultrasound
  • 4.9.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Photoacoustic
  • 4.10.1. Photoacoustic market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Reagents
  • 4.11.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
• 4.12. Services
  • 4.12.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Preclinical Imaging Application Market Movement Analysis
• 5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Research and Development
  • 5.4.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Drug Discovery
  • 5.5.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Preclinical Imaging End Use Market Movement Analysis
• 6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharma and Biotech Companies
  • 6.4.1. Pharma and biotech companies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Research Institutes
  • 6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Product, Application, End Use

• 7.1. Regional Market Share Analysis, 2025 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement structure
    • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement structure
    • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement structure
    • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement structure
    • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement structure
    • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement structure
    • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement structure
    • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement structure
    • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement structure
    • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement structure
    • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement structure
    • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement structure
    • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement structure
    • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement structure
    • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement structure
    • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement structure
    • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement structure
    • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement structure
    • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement structure
    • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement structure
    • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement structure
    • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement structure
    • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement structure
    • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2025
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders)
• 8.6. Company Profiles
  • 8.6.1. Bruker Corporation
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Siemens A.G.
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. General Electric (GE)
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. TriFoil Imaging
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. PerkinElmer, Inc.
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. VisualSonics Inc. (Fujifilm)
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Mediso Ltd.
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Agilent Technologies
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. MILabs B.V.
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. MR Solutions
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives
  • 8.6.11. Molecubes
    • 8.6.11.1. Company overview
    • 8.6.11.2. Financial performance
    • 8.6.11.3. Product benchmarking
    • 8.6.11.4. Strategic initiatives